-
Je něco špatně v tomto záznamu ?
Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics
CHP. van den Akker, JB. van Goudoever, R. Shamir, M. Domellöf, ND. Embleton, I. Hojsak, A. Lapillonne, WA. Mihatsch, R. Berni Canani, J. Bronsky, C. Campoy, MS. Fewtrell, N. Fidler Mis, A. Guarino, JM. Hulst, F. Indrio, S. Kolaček, R. Orel, Y....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- dítě MeSH
- gastroenterologie * MeSH
- kojenec MeSH
- lidé MeSH
- nekrotizující enterokolitida * epidemiologie prevence a kontrola MeSH
- novorozenec nedonošený MeSH
- novorozenec MeSH
- prebiotika MeSH
- probiotika * MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- novorozenec MeSH
- Publikační typ
- časopisecké články MeSH
More than 10,000 preterm infants have participated in randomised controlled trials on probiotics worldwide, suggesting that probiotics in general could reduce rates of necrotising enterocolitis (NEC), sepsis, and mortality. Answers to relevant clinical questions as to which strain to use, at what dosage, and how long to supplement are, however, not available. On the other hand, an increasing number of commercial products containing probiotics are available from sometimes suboptimal quality. Also, a large number of units around the world are routinely offering probiotic supplementation as the standard of care despite lacking solid evidence. Our recent network meta-analysis identified probiotic strains with greatest efficacy regarding relevant clinical outcomes for preterm neonates. Efficacy in reducing mortality and morbidity was found for only a minority of the studied strains or combinations. In the present position paper, we aim to provide advice, which specific strains might potentially be used and which strains should not be used. In addition, we aim to address safety issues of probiotic supplementation to preterm infants, who have reduced immunological capacities and occasional indwelling catheters. For example, quality reassurance of the probiotic product is essential, probiotic strains should be devoid of transferable antibiotic resistance genes, and local microbiologists should be able to routinely detect probiotic sepsis. Provided all safety issues are met, there is currently a conditional recommendation (with low certainty of evidence) to provide either Lactobacillus rhamnosus GG ATCC53103 or the combination of Bifidobacterium infantis Bb-02, Bifidobacterium lactis Bb-12, and Streptococcus thermophilus TH-4 in order to reduce NEC rates.
Childhood Nutrition Research Centre UCL GOS Institute of Child Health London UK
CNRC Baylor College of Medicine Houston TX
Department of Clinical Sciences Paediatrics Umeå University Umeå Sweden
Department of Paediatrics The Medical University of Warsaw Poland
Department of Paediatrics Ulm University and Helios Hospital Pforzheim Germany
Department of Paediatrics University Hospital Motol Prague Czech Republic
Department of Paediatrics University of Granada Spain
Faculty of Health Sciences Ben Gurion University Beer Sheva Israel
Kidz Health Castle UZ Brussel Vrije Universiteit Brussel Brussels Belgium
Paris Descartes University APHP Necker Enfants Malades hospital Paris France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020590
- 003
- CZ-PrNML
- 005
- 20210830102228.0
- 007
- ta
- 008
- 210728s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MPG.0000000000002655 $2 doi
- 035 __
- $a (PubMed)32332478
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a van den Akker, Chris H P $u Department of Paediatrics - Neonatology, Amsterdam UMC, University of Amsterdam and Vrije Universiteit Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands
- 245 10
- $a Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics / $c CHP. van den Akker, JB. van Goudoever, R. Shamir, M. Domellöf, ND. Embleton, I. Hojsak, A. Lapillonne, WA. Mihatsch, R. Berni Canani, J. Bronsky, C. Campoy, MS. Fewtrell, N. Fidler Mis, A. Guarino, JM. Hulst, F. Indrio, S. Kolaček, R. Orel, Y. Vandenplas, Z. Weizman, H. Szajewska
- 520 9_
- $a More than 10,000 preterm infants have participated in randomised controlled trials on probiotics worldwide, suggesting that probiotics in general could reduce rates of necrotising enterocolitis (NEC), sepsis, and mortality. Answers to relevant clinical questions as to which strain to use, at what dosage, and how long to supplement are, however, not available. On the other hand, an increasing number of commercial products containing probiotics are available from sometimes suboptimal quality. Also, a large number of units around the world are routinely offering probiotic supplementation as the standard of care despite lacking solid evidence. Our recent network meta-analysis identified probiotic strains with greatest efficacy regarding relevant clinical outcomes for preterm neonates. Efficacy in reducing mortality and morbidity was found for only a minority of the studied strains or combinations. In the present position paper, we aim to provide advice, which specific strains might potentially be used and which strains should not be used. In addition, we aim to address safety issues of probiotic supplementation to preterm infants, who have reduced immunological capacities and occasional indwelling catheters. For example, quality reassurance of the probiotic product is essential, probiotic strains should be devoid of transferable antibiotic resistance genes, and local microbiologists should be able to routinely detect probiotic sepsis. Provided all safety issues are met, there is currently a conditional recommendation (with low certainty of evidence) to provide either Lactobacillus rhamnosus GG ATCC53103 or the combination of Bifidobacterium infantis Bb-02, Bifidobacterium lactis Bb-12, and Streptococcus thermophilus TH-4 in order to reduce NEC rates.
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a nekrotizující enterokolitida $x epidemiologie $x prevence a kontrola $7 D020345
- 650 12
- $a gastroenterologie $7 D005762
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a novorozenec nedonošený $7 D007234
- 650 _2
- $a prebiotika $7 D056692
- 650 12
- $a probiotika $7 D019936
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a van Goudoever, Johannes B $u Department of Paediatrics - Neonatology, Amsterdam UMC, University of Amsterdam and Vrije Universiteit Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands
- 700 1_
- $a Shamir, Raanan $u Institute for Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel
- 700 1_
- $a Domellöf, Magnus $u Department of Clinical Sciences, Paediatrics, Umeå University, Umeå, Sweden
- 700 1_
- $a Embleton, Nicholas D $u Newcastle Neonatal Service, Newcastle Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, UK
- 700 1_
- $a Hojsak, Iva $u Children's Hospital Zagreb, University of Zagreb School of Medicine, University J.J. Strossmayer School of Medicine Osijek, Croatia
- 700 1_
- $a Lapillonne, Alexandre $u Paris Descartes University, APHP Necker-Enfants Malades hospital, Paris, France $u CNRC, Baylor College of Medicine, Houston, TX
- 700 1_
- $a Mihatsch, Walter A $u Department of Paediatrics, Ulm University and Helios Hospital Pforzheim, Germany
- 700 1_
- $a Berni Canani, Roberto $u Department of Translational Medical Science - Section of Paediatrics, University Federico II, Naples, Italy
- 700 1_
- $a Bronsky, Jiri $u Department of Paediatrics, University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Campoy, Cristina $u Department of Paediatrics, University of Granada, Spain
- 700 1_
- $a Fewtrell, Mary S $u Childhood Nutrition Research Centre, UCL GOS Institute of Child Health, London, UK
- 700 1_
- $a Fidler Mis, Nataša $u Department of Gastroenterology, Hepatology and Nutrition, University Medical Centre Ljubljana, University Children's Hospital Ljubljana, Slovenia
- 700 1_
- $a Guarino, Alfredo $u Department of Translational Medical Science - Section of Paediatrics, University Federico II, Naples, Italy
- 700 1_
- $a Hulst, Jessie M $u Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Hospital for Sick Children, Toronto, Canada
- 700 1_
- $a Indrio, Flavia $u Department of Paediatric Gastroenterology, Ospedale Pediatrico Giovanni XXIII, University of Bari, Italy
- 700 1_
- $a Kolaček, Sanja $u Children's Hospital Zagreb, University of Zagreb School of Medicine, University J.J. Strossmayer School of Medicine Osijek, Croatia
- 700 1_
- $a Orel, Rok $u Childhood Nutrition Research Centre, UCL GOS Institute of Child Health, London, UK
- 700 1_
- $a Vandenplas, Yvan $u Kidz Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium
- 700 1_
- $a Weizman, Zvi $u Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel
- 700 1_
- $a Szajewska, Hania $u Department of Paediatrics, The Medical University of Warsaw, Poland
- 773 0_
- $w MED00010080 $t Journal of pediatric gastroenterology and nutrition $x 1536-4801 $g Roč. 70, č. 5 (2020), s. 664-680
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32332478 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830102229 $b ABA008
- 999 __
- $a ok $b bmc $g 1691213 $s 1141036
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 70 $c 5 $d 664-680 $e - $i 1536-4801 $m Journal of pediatric gastroenterology and nutrition $n J Pediatr Gastroenterol Nutr $x MED00010080
- LZP __
- $a Pubmed-20210728
